Several conventional therapeutic options exist for the treatments for skin cancers. Other unconventional or “alternative” treatments also exist. This division between conventional and unconventional or “alternative” is, regrettably, arbitrary. In general terms, as it will become evident further on, responds more to customs and commercial convenience than to scientific principles and their consequent evidence.

The most common therapeutic strategy in cancer in general is the elimination of the tumor, using different techniques at a local level that are not particularly specific nor selective. Both invasive and non-invasive treatments can eliminate the tumor.

Added to this differentiation about invasiveness, there is another valid differentiation between treatments:

  • Those of natural origin.
  • And those of synthetic origin, developed in a laboratory.

In this regard, it’s worth mentioning that all therapeutic synthetic substances have their origin in a natural molecular model.

Lastly, in the understanding of therapeutic options, the other differentiation worth considering is between treatments that are specific and selective and those that are not. Some cells can became distorted and abnormal, and those are the cancer cells. A specific and selective treatment identifies and eliminates only those abnormal cells, respecting those cells with normal behavior.

What invasive treatments are available for skin cancers?

Invasive procedures are all those that invade our body. For example, for skin cancer, surgical excision removes the part of the skin that has the tumor, including a margin of normal skin. The Mohs technique, a type of surgical excision, uses serial biopsies to limit as much as possible the excision of healthy tissue. Similarly, other tissue destructive techniques used for treatment of skin cancers include photo and cryotherapy, or electrodessication and curettage. None of these invasive techniques is specific or selective at a cellular level.

What non-invasive treatments are available for skin cancers?

Non-invasive procedures are those that act on our body on the surface from the outside. For skin cancer treatment, there are topical treatments available such as creams with synthetic chemotherapeutic agents that are neither very selective nor specific.

The lack of specifity and selectivity of these options bring limited results.. And It implies that there may be a significant percentage of recurrence (the cancer comes back) and secondary effects.To these we must add scarring and, in certain cases, the possible need for reconstructive surgery that can include, at times, grafts.

What non-invasive, specific, selective and natural treatments are available for skin cancers?

Lastly, among the options for topical treatment there is Curaderm BCC which is a formulation of solasodine glycosides (BEC) for topical use. As we will see further on, BEC is a natural compound which acts in a very specific and selective way with an antiproliferative effect and that, in my experience, that of many other professionals and large number of scientific publications, effectively treats BCC, SCC, keratosis and keratoacanthomas with no need of other interventions and their consequences.

What is Curaderm BCC?

Curaderm BCC is a topical formulation (cream) with CE marking. Classified as a keratolytic agent, adjuvant in the treatment and cure superficial basal cell carcinoma of the skin. Curaderm BCC contains solasodine glycosides (BEC).

CuradermBCC is a keratoytic agent, adjuvant in the threatmens for skin cancers.

And… What is BEC?

BEC is a group of natural compounds extracted from the eggplant family of plants (Solanaceae). Dr. Bill E. Cham discovered it in the late 70s at the University of Queensland in Australia. When investigating on Australian ranchers’ folklore that mentioned of improvement in their cattle’s cancers by applying a poultice made from a local fruit belonging to the family of the eggplant: Solanum linnaeanum. From this plant, Dr. Cham extracted and purified BEC, which can also be found in eggplant and other plants of this family.

BEC has been extensively studied by Dr. Cham and his team at the Department of Medicine in the University of Queensland. Showing high selectivity and specificity in eliminating cancer cells without affecting normal cells. Following his numerous publications, many other research groups in the last three decades confirmed their findings.

How does BEC work?

BEC selectively eliminates abnormal (cancerous) cells which express in their surface a specific receptor with affinity for rhamnose, a plant sugar that is part of the BEC molecule.

When joined with the rhamnose receptor, BEC is internalized and triggers cell death. Given that normal cells do not express these receptors with affinity for rhamnose, BEC has no significant effect over them.

This video explains this more clearly:

How effective is BEC in the treatment of skin cancers?

There exist several publications of clinical trials using BEC in topical formulation for the treatment of proliferative skin lesions, such as basal cell carcinoma.

The Royal London Hospital Dermatology Department carried out a multicentric double-blind randomized clinical trial published in 2008. Then, the hospital treated 94 patients with basal cell carcinoma applying BEC or placebo twice daily for a maximum of 8 weeks.

The treatment duration was arbitrarily set up in 8 weeks, and the study showed a 78% cure rate. But, sometimes treatment can take up to 14 weeks depending on the size of the lesion. My experience and published studies show that the cure rate can increase up to 100% if BEC is applied until the lesion is cured.

For the treatment of actinic keratosis, a published clinical trial showed an 86% cure rate with twice daily applications for three days only. Treatments with BEC usually resolve actinic keratosis within a week. Keratoacanthomas show similar results.

All published clinical trials demonstrate that BEC in topical formulation is safe, with no significant adverse effects.

BEC’s benefits

Published studies, the clinical experience of numerous professionals, and many thousands of patients over the last 3 decades show that the treatment of basal and squamous cell carcinomas, keratosis and keratoacanthomas with topical formulations of BEC is practical, safe and effective. With no significant adverse effects. It is carried out at home without any major complications or requirements.

Considering the real costs of other treatments, the treatment with BEC’s topical formulations is also very economic.

Curaderm BCC’s manufacturer recommends its application under medical supervision.

How to apply Curaderm BCC

Apply Curaderm BCC directly over the lesion, twice or more daily. After applying, cover the lesion with paper tape to prevent the cream from drying. Repeat this process until the cancer is completely eliminated.

(for more information, see Curaderm BCC’s insert)

How many units are necessary to treat a skin lesion?

For early and small lesions, such as keratosis, one unit is usually enough. For bigger or more advanced lesions you will probably need more than one unit. It is important to consider that even once opened, Curaderm BCC’s shelf life is about 5 years if kept between 5° and 25° C.

Ok, I want it! Where do I buy Curaderm BCC?

Can be buy Curaderm BCC in our online store, and its shipped to your door.

How would I supervise the progress of my treatment of skin cancer with Curaderm BCC?

It is recommended medical supervision in the use of Curaderm BCC for the treatment of skin cancer. The health professional will be able to evaluate your response to the treatment. If you buy the product from our store, we include in the price the cost of the first 30 minutes of consultation with Dr. Gaston Cornu Labat.